APLS APELLIS PHARMACEUTICALS INC

Ownership history in Mariner, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which Mariner, LLC reported a position in APELLIS PHARMACEUTICALS INC (APLS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 43,239 +6,909 +19.0% 0.00% $978K $22.63
2025 Q2 ADDED 36,330 +23,326 +179.4% 0.00% $629K $17.31
2025 Q1 ADDED 13,004 +2,379 +22.4% 0.00% $284K $21.87
2024 Q3 REDUCED 10,625 -1,150 -9.8% 0.00% $307K $28.84
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    APLS price (monthly, adj. close)
← Back to Mariner, LLC Holdings